425 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Salvage Ovarian FANG Vaccine + Bevacizumab
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer
Interventions: Biological: FANG™ Vaccine;   Drug: Bevacizumab
22 Recruiting AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer
Intervention: Drug: AZ2281 + Carboplatin
23 Recruiting Salvage Ovarian FANG Vaccine + Carboplatinum
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer
Interventions: Biological: Vaccine: FANG™ Vaccine;   Drug: Carboplatinum;   Drug: Carboplatinum and Taxol;   Biological: FANG
24 Unknown  [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel
25 Not yet recruiting Autologous Dendritic Cell-Tumor Cell Immunotherapy for Advanced Epithelial Ovarian Carcinomas
Conditions: Stage III Ovarian Carcinoma;   Stage IV Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Biological: ovapuldencel-T;   Biological: MC: Autologous PBMCs in GM-CSF
26 Recruiting Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer;   Peritoneum Tumors
Intervention: Behavioral: Data Collection
27 Recruiting Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Procedure: Tumor Debulking Surgery (surgery in recurrent ovarian disease)
28 Unknown  A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Lovastatin and Paclitaxel
29 Recruiting Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Procedure: Cytoreductive Surgery and HIPEC;   Procedure: CRS alone
30 Recruiting Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Biological: FANG™;   Drug: Standard of care observational follow-up;   Biological: FANG™ and adjuvant chemotherapy
31 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: NGR-hTNF;   Drug: Pegylated liposomal doxorubicin;   Drug: Doxorubicin
32 Not yet recruiting Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Carboplatin and / or taxol chemotherapy
33 Recruiting A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Rucaparib
34 Unknown  Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Radiation: whole abdomen irradiation using IMRT
35 Not yet recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
36 Recruiting Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Condition: Ovarian Cancer
Interventions: Drug: Veliparib;   Drug: Topotecan
37 Unknown  Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Procedure: Seprafilm™
38 Recruiting A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Epithelial Ovarian Cancer
Interventions: Drug: CAELYX;   Drug: Topotecan HCl
39 Recruiting Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Conditions: Healthy, no Evidence of Disease;   Hereditary Breast/Ovarian Cancer - BRCA1;   Hereditary Breast/Ovarian Cancer - BRCA2
Interventions: Other: questionnaire administration;   Other: survey administration;   Other: counseling intervention;   Other: educational intervention
40 Recruiting Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years